Physician profile
Aravinda Nanjundappa
NPI 1447244488
$165,820.82
in general payments reported to CMS, 2019-2025
42 companies · $57K in 2025
The $57K reported for 2025 was more than what 97% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $4,444 · 2021: $1,459 · 2022: $765 · 2023: $18K · 2024: $53K · 2025: $57K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $50K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Travel and Lodging: $24K · Food and Beverage: $10K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,800 · Honoraria: $4,343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $50,125.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31,420.00 |
| Travel and Lodging | $24,193.15 |
| Food and Beverage | $10,120.17 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,800.00 |
| Honoraria | $4,342.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $41,414.45 | 2021-2025 | Symplicity G3, In.Pact Admiral, Abre |
| Recor Medical INC | $26,487.06 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Argon Medical Devices, INC. | $15,323.34 | 2023-2025 | Clot Management, Clot Management, Cleaner |
| Medtronic Vascular, INC. | $13,358.51 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12,792.51 | 2019-2025 | Lifevest |
| Abbott Laboratories | $9,281.74 | 2019-2025 | Diamondback Coronary, Amplatzer, Perclose Proglide |
| Shockwave Medical, INC | $8,369.92 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Livanova USA, INC. | $7,287.71 | 2019 | |
| W. L. Gore & Associates, INC. | $7,252.46 | 2019-2020 | |
| Biotronik INC. | $4,273.66 | 2024-2025 | Oscar, Pulsar-18 T3 |
| Penumbra, INC. | $3,962.13 | 2019-2025 | Indigo System, Penumbra System |
| Philips North America LLC | $3,639.32 | 2019-2025 | (9520) Igt Devices Undivided, (Bs2) Lm Undivided, (Am5) Lead Management |
| Pfizer INC. | $2,748.46 | 2019 | |
| Celonova Biosciences, INC. | $2,386.29 | 2019-2020 | |
| Teleflex LLC | $1,523.81 | 2025 | Oscar |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $1,431.35 | 2019-2025 | Glidewire, R2p Misago, Glidesheath Slender |
| Boston Scientific Corporation | $1,326.52 | 2019-2022 | |
| Cook Medical LLC | $368.12 | 2019-2023 | Zenith Alpha, Zilver Ptx |
| Cardiovascular Systems INC. | $320.14 | 2019-2023 | Diamondback Peripheral, Diamondback Coronary |
| Medicure Pharma INC. | $300.00 | 2021 | |
| Surmodics, INC. | $243.47 | 2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Abiomed | $204.30 | 2019-2021 | |
| Osprey Medical INC | $177.08 | 2020-2021 | |
| Angiodynamics, INC. | $167.78 | 2023-2024 | Angiovac |
| Inari Medical, INC. | $156.21 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bard Peripheral Vascular, INC. | $137.54 | 2019-2025 | Venovo |
| Contego Medical, INC | $131.24 | 2024 | |
| Siemens Medical Solutions USA, INC. | $130.18 | 2020 | |
| Cardinal Health 200 LLC | $96.91 | 2019 | |
| Amgen INC. | $96.85 | 2023-2024 | Repatha |
| Silk Road Medical, INC. | $85.89 | 2020 | |
| Edwards Lifesciences Corporation | $77.60 | 2019 | |
| Zoll Circulation INC | $72.77 | 2022 | |
| Cvrx, INC. | $72.39 | 2024 | Barostim Neo System |
| Novo Nordisk INC | $50.00 | 2025 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $29.42 | 2020 | |
| Novartis Pharmaceuticals Corporation | $15.42 | 2022 | |
| Asahi Intecc USA, INC. | $14.79 | 2024 | Peripheral Vascular |
| Cordis US Corp. | $13.48 | 2025 | Mynx Control Venous |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,500.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aravinda Nanjundappa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.